Global Cancer Diagnostics Industry
Global Cancer Diagnostics Market to Reach $223. 3 Billion by 2027. Amid the COVID-19 crisis, the global market for Cancer Diagnostics estimated at US$150. 6 Billion in the year 2020, is projected to reach a revised size of US$223.
New York, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Cancer Diagnostics Industry" - https://www.reportlinker.com/p05956209/?utm_source=GNW
3 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. Laboratory Tests, one of the segments analyzed in the report, is projected to record a 5.4% CAGR and reach US$50.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Genetic Tests segment is readjusted to a revised 6.4% CAGR for the next 7-year period.
The U.S. Market is Estimated at $40.8 Billion, While China is Forecast to Grow at 8.8% CAGR
The Cancer Diagnostics market in the U.S. is estimated at US$40.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$46.7 Billion by the year 2027 trailing a CAGR of 8.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.
Imaging Segment to Record 6.2% CAGR
In the global Imaging segment, USA, Canada, Japan, China and Europe will drive the 5.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$28.4 Billion in the year 2020 will reach a projected size of US$41.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$30.1 Billion by the year 2027, while Latin America will expand at a 7.4% CAGR through the analysis period. We bring years of research experience to this 7th edition of our report. The 308-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,
Abbott Diagnostics
Abbott Laboratories
Agilent Technologies, Inc.
Ambry Genetics Corporation
Applied Imaging
AstraZeneca PLC
AutoGenomics, Inc.
BARD, A Becton, Dickinson Company
Bayer AG
Becton, Dickinson and Company
BioCurex, Inc.
bioMeriux SA
Celara Diagnostics
Diagnostic Products Corporation
Eli Lilly and Company
F. Hoffmann-La Roche AG
GE Healthcare
Genoptix, Inc.
GlaxoSmithKline PLC
Hologic, Inc.
Illumina, Inc.
Pfizer, Inc.
Philips Healthcare
QIAGEN GmbH
Siemens Healthineers
Thermo Fisher Scientific, Inc.
Read the full report: https://www.reportlinker.com/p05956209/?utm_source=GNW
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Cancer Diagnostics Competitor Market Share Scenario Worldwide
(in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Cancer Diagnostics Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027
Table 2: Cancer Diagnostics Global Retrospective Market
Scenario in US$ Million by Region/Country: 2012-2019
Table 3: Cancer Diagnostics Market Share Shift across Key
Geographies Worldwide: 2012 VS 2020 VS 2027
Table 4: Laboratory Tests (Type) World Market by Region/Country
in US$ Million: 2020 to 2027
Table 5: Laboratory Tests (Type) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019
Table 6: Laboratory Tests (Type) Market Share Breakdown of
Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
Table 7: Genetic Tests (Type) Potential Growth Markets
Worldwide in US$ Million: 2020 to 2027
Table 8: Genetic Tests (Type) Historic Market Perspective by
Region/Country in US$ Million: 2012 to 2019
Table 9: Genetic Tests (Type) Market Sales Breakdown by
Region/Country in Percentage: 2012 VS 2020 VS 2027
Table 10: Imaging (Type) Geographic Market Spread Worldwide in
US$ Million: 2020 to 2027
Table 11: Imaging (Type) Region Wise Breakdown of Global
Historic Demand in US$ Million: 2012 to 2019
Table 12: Imaging (Type) Market Share Distribution in
Percentage by Region/Country: 2012 VS 2020 VS 2027
Table 13: Endoscopy (Type) World Market Estimates and Forecasts
by Region/Country in US$ Million: 2020 to 2027
Table 14: Endoscopy (Type) Market Historic Review by
Region/Country in US$ Million: 2012 to 2019
Table 15: Endoscopy (Type) Market Share Breakdown by
Region/Country: 2012 VS 2020 VS 2027
Table 16: Biopsy (Type) World Market by Region/Country in US$
Million: 2020 to 2027
Table 17: Biopsy (Type) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019
Table 18: Biopsy (Type) Market Share Distribution in Percentage
by Region/Country: 2012 VS 2020 VS 2027
Table 19: Other Types (Type) World Market Estimates and
Forecasts in US$ Million by Region/Country: 2020 to 2027
Table 20: Other Types (Type) Market Worldwide Historic Review
by Region/Country in US$ Million: 2012 to 2019
Table 21: Other Types (Type) Market Percentage Share
Distribution by Region/Country: 2012 VS 2020 VS 2027
Table 22: Breast (Application) Global Opportunity Assessment in
US$ Million by Region/Country: 2020-2027
Table 23: Breast (Application) Historic Sales Analysis in US$
Million by Region/Country: 2012-2019
Table 24: Breast (Application) Percentage Share Breakdown of
Global Sales by Region/Country: 2012 VS 2020 VS 2027
Table 25: Lung (Application) Worldwide Sales in US$ Million by
Region/Country: 2020-2027
Table 26: Lung (Application) Historic Demand Patterns in US$
Million by Region/Country: 2012-2019
Table 27: Lung (Application) Market Share Shift across Key
Geographies: 2012 VS 2020 VS 2027
Table 28: Colorectal (Application) Global Market Estimates &
Forecasts in US$ Million by Region/Country: 2020-2027
Table 29: Colorectal (Application) Retrospective Demand
Analysis in US$ Million by Region/Country: 2012-2019
Table 30: Colorectal (Application) Market Share Breakdown by
Region/Country: 2012 VS 2020 VS 2027
Table 31: Skin (Application) Demand Potential Worldwide in US$
Million by Region/Country: 2020-2027
Table 32: Skin (Application) Historic Sales Analysis in US$
Million by Region/Country: 2012-2019
Table 33: Skin (Application) Share Breakdown Review by
Region/Country: 2012 VS 2020 VS 2027
Table 34: Prostate (Application) Worldwide Latent Demand
Forecasts in US$ Million by Region/Country: 2020-2027
Table 35: Prostate (Application) Global Historic Analysis in
US$ Million by Region/Country: 2012-2019
Table 36: Prostate (Application) Distribution of Global Sales
by Region/Country: 2012 VS 2020 VS 2027
Table 37: Blood (Application) Sales Estimates and Forecasts in
US$ Million by Region/Country for the Years 2020 through 2027
Table 38: Blood (Application) Analysis of Historic Sales in US$
Million by Region/Country for the Years 2012 to 2019
Table 39: Blood (Application) Global Market Share Distribution
by Region/Country for 2012, 2020, and 2027
Table 40: Ovarian (Application) Global Opportunity Assessment
in US$ Million by Region/Country: 2020-2027
Table 41: Ovarian (Application) Historic Sales Analysis in US$
Million by Region/Country: 2012-2019
Table 42: Ovarian (Application) Percentage Share Breakdown of
Global Sales by Region/Country: 2012 VS 2020 VS 2027
Table 43: Other Applications (Application) Worldwide Sales in
US$ Million by Region/Country: 2020-2027
Table 44: Other Applications (Application) Historic Demand
Patterns in US$ Million by Region/Country: 2012-2019
Table 45: Other Applications (Application) Market Share Shift
across Key Geographies: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Cancer Diagnostics Market Share (in %) by Company: 2019 & 2025
Market Analytics
Table 46: United States Cancer Diagnostics Market Estimates and
Projections in US$ Million by Type: 2020 to 2027
Table 47: Cancer Diagnostics Market in the United States by
Type: A Historic Review in US$ Million for 2012-2019
Table 48: United States Cancer Diagnostics Market Share
Breakdown by Type: 2012 VS 2020 VS 2027
Table 49: United States Cancer Diagnostics Latent Demand
Forecasts in US$ Million by Application: 2020 to 2027
Table 50: Cancer Diagnostics Historic Demand Patterns in the
United States by Application in US$ Million for 2012-2019
Table 51: Cancer Diagnostics Market Share Breakdown in the
United States by Application: 2012 VS 2020 VS 2027
CANADA
Table 52: Canadian Cancer Diagnostics Market Estimates and
Forecasts in US$ Million by Type: 2020 to 2027
Table 53: Canadian Cancer Diagnostics Historic Market Review by
Type in US$ Million: 2012-2019
Table 54: Cancer Diagnostics Market in Canada: Percentage Share
Breakdown of Sales by Type for 2012, 2020, and 2027
Table 55: Canadian Cancer Diagnostics Market Quantitative
Demand Analysis in US$ Million by Application: 2020 to 2027
Table 56: Cancer Diagnostics Market in Canada: Summarization of
Historic Demand Patterns in US$ Million by Application for
2012-2019
Table 57: Canadian Cancer Diagnostics Market Share Analysis by
Application: 2012 VS 2020 VS 2027
JAPAN
Table 58: Japanese Market for Cancer Diagnostics: Annual Sales
Estimates and Projections in US$ Million by Type for the Period
2020-2027
Table 59: Cancer Diagnostics Market in Japan: Historic Sales
Analysis in US$ Million by Type for the Period 2012-2019
Table 60: Japanese Cancer Diagnostics Market Share Analysis by
Type: 2012 VS 2020 VS 2027
Table 61: Japanese Demand Estimates and Forecasts for Cancer
Diagnostics in US$ Million by Application: 2020 to 2027
Table 62: Japanese Cancer Diagnostics Market in US$ Million by
Application: 2012-2019
Table 63: Cancer Diagnostics Market Share Shift in Japan by
Application: 2012 VS 2020 VS 2027
CHINA
Table 64: Chinese Cancer Diagnostics Market Growth Prospects in
US$ Million by Type for the Period 2020-2027
Table 65: Cancer Diagnostics Historic Market Analysis in China
in US$ Million by Type: 2012-2019
Table 66: Chinese Cancer Diagnostics Market by Type: Percentage
Breakdown of Sales for 2012, 2020, and 2027
Table 67: Chinese Demand for Cancer Diagnostics in US$ Million
by Application: 2020 to 2027
Table 68: Cancer Diagnostics Market Review in China in US$
Million by Application: 2012-2019
Table 69: Chinese Cancer Diagnostics Market Share Breakdown by
Application: 2012 VS 2020 VS 2027
EUROPE
Market Facts & Figures
European Cancer Diagnostics Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Market Analytics
Table 70: European Cancer Diagnostics Market Demand Scenario in
US$ Million by Region/Country: 2020-2027
Table 71: Cancer Diagnostics Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2012-2019
Table 72: European Cancer Diagnostics Market Share Shift by
Region/Country: 2012 VS 2020 VS 2027
Table 73: European Cancer Diagnostics Market Estimates and
Forecasts in US$ Million by Type: 2020-2027
Table 74: Cancer Diagnostics Market in Europe in US$ Million by
Type: A Historic Review for the Period 2012-2019
Table 75: European Cancer Diagnostics Market Share Breakdown by
Type: 2012 VS 2020 VS 2027
Table 76: European Cancer Diagnostics Addressable Market
Opportunity in US$ Million by Application: 2020-2027
Table 77: Cancer Diagnostics Market in Europe: Summarization of
Historic Demand in US$ Million by Application for the Period
2012-2019
Table 78: European Cancer Diagnostics Market Share Analysis by
Application: 2012 VS 2020 VS 2027
FRANCE
Table 79: Cancer Diagnostics Market in France by Type:
Estimates and Projections in US$ Million for the Period
2020-2027
Table 80: French Cancer Diagnostics Historic Market Scenario in
US$ Million by Type: 2012-2019
Table 81: French Cancer Diagnostics Market Share Analysis by
Type: 2012 VS 2020 VS 2027
Table 82: Cancer Diagnostics Quantitative Demand Analysis in
France in US$ Million by Application: 2020-2027
Table 83: French Cancer Diagnostics Historic Market Review in
US$ Million by Application: 2012-2019
Table 84: French Cancer Diagnostics Market Share Analysis:
A 17-Year Perspective by Application for 2012, 2020, and 2027
GERMANY
Table 85: Cancer Diagnostics Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Type for the
Period 2020-2027
Table 86: German Cancer Diagnostics Historic Market Analysis in
US$ Million by Type: 2012-2019
Table 87: German Cancer Diagnostics Market Share Breakdown by
Type: 2012 VS 2020 VS 2027
Table 88: Cancer Diagnostics Market in Germany: Annual Sales
Estimates and Forecasts in US$ Million by Application for the
Period 2020-2027
Table 89: German Cancer Diagnostics Market in Retrospect in US$
Million by Application: 2012-2019
Table 90: Cancer Diagnostics Market Share Distribution in
Germany by Application: 2012 VS 2020 VS 2027
ITALY
Table 91: Italian Cancer Diagnostics Market Growth Prospects in
US$ Million by Type for the Period 2020-2027
Table 92: Cancer Diagnostics Historic Market Analysis in Italy
in US$ Million by Type: 2012-2019
Table 93: Italian Cancer Diagnostics Market by Type: Percentage
Breakdown of Sales for 2012, 2020, and 2027
Table 94: Italian Demand for Cancer Diagnostics in US$ Million
by Application: 2020 to 2027
Table 95: Cancer Diagnostics Market Review in Italy in US$
Million by Application: 2012-2019
Table 96: Italian Cancer Diagnostics Market Share Breakdown by
Application: 2012 VS 2020 VS 2027
UNITED KINGDOM
Table 97: United Kingdom Market for Cancer Diagnostics: Annual
Sales Estimates and Projections in US$ Million by Type for the
Period 2020-2027
Table 98: Cancer Diagnostics Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Type for the Period
2012-2019
Table 99: United Kingdom Cancer Diagnostics Market Share
Analysis by Type: 2012 VS 2020 VS 2027
Table 100: United Kingdom Demand Estimates and Forecasts for
Cancer Diagnostics in US$ Million by Application: 2020 to 2027
Table 101: United Kingdom Cancer Diagnostics Market in US$
Million by Application: 2012-2019
Table 102: Cancer Diagnostics Market Share Shift in the United
Kingdom by Application: 2012 VS 2020 VS 2027
SPAIN
Table 103: Spanish Cancer Diagnostics Market Estimates and
Forecasts in US$ Million by Type: 2020 to 2027
Table 104: Spanish Cancer Diagnostics Historic Market Review by
Type in US$ Million: 2012-2019
Table 105: Cancer Diagnostics Market in Spain: Percentage Share
Breakdown of Sales by Type for 2012, 2020, and 2027
Table 106: Spanish Cancer Diagnostics Market Quantitative
Demand Analysis in US$ Million by Application: 2020 to 2027
Table 107: Cancer Diagnostics Market in Spain: Summarization of
Historic Demand Patterns in US$ Million by Application for
2012-2019
Table 108: Spanish Cancer Diagnostics Market Share Analysis by
Application: 2012 VS 2020 VS 2027
RUSSIA
Table 109: Russian Cancer Diagnostics Market Estimates and
Projections in US$ Million by Type: 2020 to 2027
Table 110: Cancer Diagnostics Market in Russia by Type:
A Historic Review in US$ Million for 2012-2019
Table 111: Russian Cancer Diagnostics Market Share Breakdown by
Type: 2012 VS 2020 VS 2027
Table 112: Russian Cancer Diagnostics Latent Demand Forecasts
in US$ Million by Application: 2020 to 2027
Table 113: Cancer Diagnostics Historic Demand Patterns in
Russia by Application in US$ Million for 2012-2019
Table 114: Cancer Diagnostics Market Share Breakdown in Russia
by Application: 2012 VS 2020 VS 2027
REST OF EUROPE
Table 115: Rest of Europe Cancer Diagnostics Market Estimates
and Forecasts in US$ Million by Type: 2020-2027
Table 116: Cancer Diagnostics Market in Rest of Europe in US$
Million by Type: A Historic Review for the Period 2012-2019
Table 117: Rest of Europe Cancer Diagnostics Market Share
Breakdown by Type: 2012 VS 2020 VS 2027
Table 118: Rest of Europe Cancer Diagnostics Addressable Market
Opportunity in US$ Million by Application: 2020-2027
Table 119: Cancer Diagnostics Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by Application
for the Period 2012-2019
Table 120: Rest of Europe Cancer Diagnostics Market Share
Analysis by Application: 2012 VS 2020 VS 2027
ASIA-PACIFIC
Table 121: Asia-Pacific Cancer Diagnostics Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027
Table 122: Cancer Diagnostics Market in Asia-Pacific: Historic
Market Analysis in US$ Million by Region/Country for the Period
2012-2019
Table 123: Asia-Pacific Cancer Diagnostics Market Share
Analysis by Region/Country: 2012 VS 2020 VS 2027
Table 124: Cancer Diagnostics Market in Asia-Pacific by Type:
Estimates and Projections in US$ Million for the Period
2020-2027
Table 125: Asia-Pacific Cancer Diagnostics Historic Market
Scenario in US$ Million by Type: 2012-2019
Table 126: Asia-Pacific Cancer Diagnostics Market Share
Analysis by Type: 2012 VS 2020 VS 2027
Table 127: Cancer Diagnostics Quantitative Demand Analysis in
Asia-Pacific in US$ Million by Application: 2020-2027
Table 128: Asia-Pacific Cancer Diagnostics Historic Market
Review in US$ Million by Application: 2012-2019
Table 129: Asia-Pacific Cancer Diagnostics Market Share
Analysis: A 17-Year Perspective by Application for 2012, 2020,
and 2027
AUSTRALIA
Table 130: Cancer Diagnostics Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Type for the
Period 2020-2027
Table 131: Australian Cancer Diagnostics Historic Market
Analysis in US$ Million by Type: 2012-2019
Table 132: Australian Cancer Diagnostics Market Share Breakdown
by Type: 2012 VS 2020 VS 2027
Table 133: Cancer Diagnostics Market in Australia: Annual Sales
Estimates and Forecasts in US$ Million by Application for the
Period 2020-2027
Table 134: Australian Cancer Diagnostics Market in Retrospect
in US$ Million by Application: 2012-2019
Table 135: Cancer Diagnostics Market Share Distribution in
Australia by Application: 2012 VS 2020 VS 2027
INDIA
Table 136: Indian Cancer Diagnostics Market Estimates and
Forecasts in US$ Million by Type: 2020 to 2027
Table 137: Indian Cancer Diagnostics Historic Market Review by
Type in US$ Million: 2012-2019
Table 138: Cancer Diagnostics Market in India: Percentage Share
Breakdown of Sales by Type for 2012, 2020, and 2027
Table 139: Indian Cancer Diagnostics Market Quantitative Demand
Analysis in US$ Million by Application: 2020 to 2027
Table 140: Cancer Diagnostics Market in India: Summarization of
Historic Demand Patterns in US$ Million by Application for
2012-2019
Table 141: Indian Cancer Diagnostics Market Share Analysis by
Application: 2012 VS 2020 VS 2027
SOUTH KOREA
Table 142: Cancer Diagnostics Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Type for
the Period 2020-2027
Table 143: South Korean Cancer Diagnostics Historic Market
Analysis in US$ Million by Type: 2012-2019
Table 144: Cancer Diagnostics Market Share Distribution in
South Korea by Type: 2012 VS 2020 VS 2027
Table 145: Cancer Diagnostics Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Application
for the Period 2020-2027
Table 146: South Korean Cancer Diagnostics Historic Market
Analysis in US$ Million by Application: 2012-2019
Table 147: Cancer Diagnostics Market Share Distribution in
South Korea by Application: 2012 VS 2020 VS 2027
REST OF ASIA-PACIFIC
Table 148: Rest of Asia-Pacific Market for Cancer Diagnostics:
Annual Sales Estimates and Projections in US$ Million by Type
for the Period 2020-2027
Table 149: Cancer Diagnostics Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Million by Type for the Period
2012-2019
Table 150: Rest of Asia-Pacific Cancer Diagnostics Market Share
Analysis by Type: 2012 VS 2020 VS 2027
Table 151: Rest of Asia-Pacific Demand Estimates and Forecasts
for Cancer Diagnostics in US$ Million by Application: 2020 to
2027
Table 152: Rest of Asia-Pacific Cancer Diagnostics Market in
US$ Million by Application: 2012-2019
Table 153: Cancer Diagnostics Market Share Shift in Rest of
Asia-Pacific by Application: 2012 VS 2020 VS 2027
LATIN AMERICA
Table 154: Latin American Cancer Diagnostics Market Trends by
Region/Country in US$ Million: 2020-2027
Table 155: Cancer Diagnostics Market in Latin America in US$
Million by Region/Country: A Historic Perspective for the
Period 2012-2019
Table 156: Latin American Cancer Diagnostics Market Percentage
Breakdown of Sales by Region/Country: 2012, 2020, and 2027
Table 157: Latin American Cancer Diagnostics Market Growth
Prospects in US$ Million by Type for the Period 2020-2027
Table 158: Cancer Diagnostics Historic Market Analysis in Latin
America in US$ Million by Type: 2012-2019
Table 159: Latin American Cancer Diagnostics Market by Type:
Percentage Breakdown of Sales for 2012, 2020, and 2027
Table 160: Latin American Demand for Cancer Diagnostics in US$
Million by Application: 2020 to 2027
Table 161: Cancer Diagnostics Market Review in Latin America in
US$ Million by Application: 2012-2019
Table 162: Latin American Cancer Diagnostics Market Share
Breakdown by Application: 2012 VS 2020 VS 2027
ARGENTINA
Table 163: Argentinean Cancer Diagnostics Market Estimates and
Forecasts in US$ Million by Type: 2020-2027
Table 164: Cancer Diagnostics Market in Argentina in US$
Million by Type: A Historic Review for the Period 2012-2019
Table 165: Argentinean Cancer Diagnostics Market Share
Breakdown by Type: 2012 VS 2020 VS 2027
Table 166: Argentinean Cancer Diagnostics Addressable Market
Opportunity in US$ Million by Application: 2020-2027
Table 167: Cancer Diagnostics Market in Argentina:
Summarization of Historic Demand in US$ Million by Application
for the Period 2012-2019
Table 168: Argentinean Cancer Diagnostics Market Share Analysis
by Application: 2012 VS 2020 VS 2027
BRAZIL
Table 169: Cancer Diagnostics Market in Brazil by Type:
Estimates and Projections in US$ Million for the Period
2020-2027
Table 170: Brazilian Cancer Diagnostics Historic Market
Scenario in US$ Million by Type: 2012-2019
Table 171: Brazilian Cancer Diagnostics Market Share Analysis
by Type: 2012 VS 2020 VS 2027
Table 172: Cancer Diagnostics Quantitative Demand Analysis in
Brazil in US$ Million by Application: 2020-2027
Table 173: Brazilian Cancer Diagnostics Historic Market Review
in US$ Million by Application: 2012-2019
Table 174: Brazilian Cancer Diagnostics Market Share Analysis:
A 17-Year Perspective by Application for 2012, 2020, and 2027
MEXICO
Table 175: Cancer Diagnostics Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Type for the
Period 2020-2027
Table 176: Mexican Cancer Diagnostics Historic Market Analysis
in US$ Million by Type: 2012-2019
Table 177: Mexican Cancer Diagnostics Market Share Breakdown by
Type: 2012 VS 2020 VS 2027
Table 178: Cancer Diagnostics Market in Mexico: Annual Sales
Estimates and Forecasts in US$ Million by Application for the
Period 2020-2027
Table 179: Mexican Cancer Diagnostics Market in Retrospect in
US$ Million by Application: 2012-2019
Table 180: Cancer Diagnostics Market Share Distribution in
Mexico by Application: 2012 VS 2020 VS 2027
REST OF LATIN AMERICA
Table 181: Rest of Latin America Cancer Diagnostics Market
Estimates and Projections in US$ Million by Type: 2020 to 2027
Table 182: Cancer Diagnostics Market in Rest of Latin America
by Type: A Historic Review in US$ Million for 2012-2019
Table 183: Rest of Latin America Cancer Diagnostics Market
Share Breakdown by Type: 2012 VS 2020 VS 2027
Table 184: Rest of Latin America Cancer Diagnostics Latent
Demand Forecasts in US$ Million by Application: 2020 to 2027
Table 185: Cancer Diagnostics Historic Demand Patterns in Rest
of Latin America by Application in US$ Million for 2012-2019
Table 186: Cancer Diagnostics Market Share Breakdown in Rest of
Latin America by Application: 2012 VS 2020 VS 2027
MIDDLE EAST
Table 187: The Middle East Cancer Diagnostics Market Estimates
and Forecasts in US$ Million by Region/Country: 2020-2027
Table 188: Cancer Diagnostics Market in the Middle East by
Region/Country in US$ Million: 2012-2019
Table 189: The Middle East Cancer Diagnostics Market Share
Breakdown by Region/Country: 2012, 2020, and 2027
Table 190: The Middle East Cancer Diagnostics Market Estimates
and Forecasts in US$ Million by Type: 2020 to 2027
Table 191: The Middle East Cancer Diagnostics Historic Market
by Type in US$ Million: 2012-2019
Table 192: Cancer Diagnostics Market in the Middle East:
Percentage Share Breakdown of Sales by Type for 2012,2020, and
2027
Table 193: The Middle East Cancer Diagnostics Market
Quantitative Demand Analysis in US$ Million by Application:
2020 to 2027
Table 194: Cancer Diagnostics Market in the Middle East:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2012-2019
Table 195: The Middle East Cancer Diagnostics Market Share
Analysis by Application: 2012 VS 2020 VS 2027
IRAN
Table 196: Iranian Market for Cancer Diagnostics: Annual Sales
Estimates and Projections in US$ Million by Type for the Period
2020-2027
Table 197: Cancer Diagnostics Market in Iran: Historic Sales
Analysis in US$ Million by Type for the Period 2012-2019
Table 198: Iranian Cancer Diagnostics Market Share Analysis by
Type: 2012 VS 2020 VS 2027
Table 199: Iranian Demand Estimates and Forecasts for Cancer
Diagnostics in US$ Million by Application: 2020 to 2027
Table 200: Iranian Cancer Diagnostics Market in US$ Million by
Application: 2012-2019
Table 201: Cancer Diagnostics Market Share Shift in Iran by
Application: 2012 VS 2020 VS 2027
ISRAEL
Table 202: Israeli Cancer Diagnostics Market Estimates and
Forecasts in US$ Million by Type: 2020-2027
Table 203: Cancer Diagnostics Market in Israel in US$ Million
by Type: A Historic Review for the Period 2012-2019
Table 204: Israeli Cancer Diagnostics Market Share Breakdown by
Type: 2012 VS 2020 VS 2027
Table 205: Israeli Cancer Diagnostics Addressable Market
Opportunity in US$ Million by Application: 2020-2027
Table 206: Cancer Diagnostics Market in Israel: Summarization
of Historic Demand in US$ Million by Application for the Period
2012-2019
Table 207: Israeli Cancer Diagnostics Market Share Analysis by
Application: 2012 VS 2020 VS 2027
SAUDI ARABIA
Table 208: Saudi Arabian Cancer Diagnostics Market Growth
Prospects in US$ Million by Type for the Period 2020-2027
Table 209: Cancer Diagnostics Historic Market Analysis in Saudi
Arabia in US$ Million by Type: 2012-2019
Table 210: Saudi Arabian Cancer Diagnostics Market by Type:
Percentage Breakdown of Sales for 2012, 2020, and 2027
Table 211: Saudi Arabian Demand for Cancer Diagnostics in US$
Million by Application: 2020 to 2027
Table 212: Cancer Diagnostics Market Review in Saudi Arabia in
US$ Million by Application: 2012-2019
Table 213: Saudi Arabian Cancer Diagnostics Market Share
Breakdown by Application: 2012 VS 2020 VS 2027
UNITED ARAB EMIRATES
Table 214: Cancer Diagnostics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Type for the Period 2020-2027
Table 215: United Arab Emirates Cancer Diagnostics Historic
Market Analysis in US$ Million by Type: 2012-2019
Table 216: Cancer Diagnostics Market Share Distribution in
United Arab Emirates by Type: 2012 VS 2020 VS 2027
Table 217: Cancer Diagnostics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Application for the Period 2020-2027
Table 218: United Arab Emirates Cancer Diagnostics Historic
Market Analysis in US$ Million by Application: 2012-2019
Table 219: Cancer Diagnostics Market Share Distribution in
United Arab Emirates by Application: 2012 VS 2020 VS 2027
REST OF MIDDLE EAST
Table 220: Cancer Diagnostics Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Million by Type
for the Period 2020-2027
Table 221: Rest of Middle East Cancer Diagnostics Historic
Market Analysis in US$ Million by Type: 2012-2019
Table 222: Rest of Middle East Cancer Diagnostics Market Share
Breakdown by Type: 2012 VS 2020 VS 2027
Table 223: Cancer Diagnostics Market in Rest of Middle East:
Annual Sales Estimates and Forecasts in US$ Million by
Application for the Period 2020-2027
Table 224: Rest of Middle East Cancer Diagnostics Market in
Retrospect in US$ Million by Application: 2012-2019
Table 225: Cancer Diagnostics Market Share Distribution in Rest
of Middle East by Application: 2012 VS 2020 VS 2027
AFRICA
Table 226: African Cancer Diagnostics Market Estimates and
Projections in US$ Million by Type: 2020 to 2027
Table 227: Cancer Diagnostics Market in Africa by Type:
A Historic Review in US$ Million for 2012-2019
Table 228: African Cancer Diagnostics Market Share Breakdown by
Type: 2012 VS 2020 VS 2027
Table 229: African Cancer Diagnostics Latent Demand Forecasts
in US$ Million by Application: 2020 to 2027
Table 230: Cancer Diagnostics Historic Demand Patterns in
Africa by Application in US$ Million for 2012-2019
Table 231: Cancer Diagnostics Market Share Breakdown in Africa
by Application: 2012 VS 2020 VS 2027
IV. COMPETITION
Total Companies Profiled: 47
Read the full report: https://www.reportlinker.com/p05956209/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001